Scientific Industries appoints Michael Blechman as Class B Director and committee chair

SCIENTIFIC INDUSTRIES INC

Michael Blechman appointed Class B Director, effective April 12, 2024.
Will serve on audit and compensation committees, and chair nominating committee.
Blechman, 65, was CEO of ACC Inc. from 2017 to 2023 and a consultant since Feb 2023.
No family relationships or material transactions with the company disclosed.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael Blechman

Class B Director

SCND · SCIENTIFIC INDUSTRIES INC

Effective: 2024-04-12
Filed: April 15, 2024, 7:59 PM ET

On April 12, 2024, the Board of Directors (the “Board”) of Scientific Industries Inc. (the “Company”) appointed Michael Blechman (i) as a Class B Director of the Company, (ii) a member of the Board’s audit committee, (iii) a member of the Board’s compensation committee, and (iv) the Chair and member of the Company’s Nominating Committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Michael Blechman was appointed as Class B Director at SCIENTIFIC INDUSTRIES INC.

Action: appointed
Role: Class B Director

Exact text from the filing

On April 12, 2024, the Board of Directors (the “Board”) of Scientific Industries Inc. (the “Company”) appointed Michael Blechman (i) as a Class B Director of the Company, (ii) a member of the Board’s audit committee, (iii) a member of the Board’s compensation committee, and (iv) the Chair and member of the Company’s Nominating Committee.

View on SEC.gov

SCIENTIFIC INDUSTRIES INC filing history →

Source: SEC EDGAR

accession 0001654954-24-004632

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.